Literature DB >> 22250184

Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry.

Alejandro Lucia1, Jonatan R Ruiz, Alfredo Santalla, Gisela Nogales-Gadea, Juan C Rubio, Inés García-Consuegra, Ana Cabello, Margarita Pérez, Susana Teijeira, Irene Vieitez, Carmen Navarro, Joaquín Arenas, Miguel A Martin, Antoni L Andreu.   

Abstract

BACKGROUND: Published genotype/phenotype data on McArdle disease are limited in sample size. A single national (Spanish) registry of patients with McArdle disease was created with the purpose of analysing their genotypic and phenotypic characteristics.
METHODS: A cross sectional study was conducted, collecting demographic, family history, clinical, genotype and functional capacity data from all patients diagnosed with McArdle disease in the Spanish National Health System up to December 2010.
RESULTS: 239 cases were recorded (all of Caucasian descent, 102 women; mean±SD age 44±18 years (range 9, 93)); prevalence of ∼1/167 000 people. Two mutant PYGM alleles were identified in 99.6% of cases. Although there was heterogeneity in the severity of symptoms, there were four common diagnostic features: (1) 99.5% of patients reported a history of acute crises of exercise intolerance (accompanied by recurrent myoglobinuria in 50% of cases); (2) in 58% of patients, symptoms started in the first decade of life; (3) 86% of patients repeatedly experienced the 'second wind' phenomenon over life; and (4) 99% of patients had a high basal serum level of total creatine kinase (>200 U/l). Clinical presentation of the disease was similar in men and women and worsened with age. Patients who were physically active had higher levels of cardiorespiratory fitness (by 23%, p=0.003) and were more likely to improve their clinical course over a 4 year period compared with inactive patients (OR 225; 95% CI 20.3 to 2496.7).
CONCLUSIONS: The main clinical features of McArdle disease are generally homogeneous and frequently appear during childhood; clinical condition deteriorates with ageing. Active patients have a better clinical outcome and functional capacity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22250184     DOI: 10.1136/jnnp-2011-301593

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  40 in total

Review 1.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

2.  Therapeutic advances in the management of Pompe disease and other metabolic myopathies.

Authors:  Corrado Angelini; Anna Chiara Nascimbeni; Claudio Semplicini
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

3.  Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.

Authors:  Carmen Fiuza-Luces; Alejandro Santos-Lozano; Francisco Llavero; Rocío Campo; Gisela Nogales-Gadea; Jorge Díez-Bermejo; Carlos Baladrón; África González-Murillo; Joaquín Arenas; Miguel A Martín; Antoni L Andreu; Tomàs Pinós; Beatriz G Gálvez; Juan A López; Jesús Vázquez; José L Zugaza; Alejandro Lucia
Journal:  J Physiol       Date:  2018-02-14       Impact factor: 5.182

Review 4.  Gene therapy for glycogen storage diseases.

Authors:  Priya S Kishnani; Baodong Sun; Dwight D Koeberl
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 5.  McArdle disease: a unique study model in sports medicine.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Niels Ørtenblad; Astrid Brull; Noemi de Luna; Tomàs Pinós; Alejandro Lucia
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

6.  Low versus high carbohydrates in the diet of the world-class athlete: insights from McArdle's disease.

Authors:  Gisela Nogales-Gadea; Alfredo Santalla; Joaquín Arenas; Miguel A Martín; María Morán; Alejandro Lucia
Journal:  J Physiol       Date:  2017-05-01       Impact factor: 5.182

Review 7.  Neuromuscular disorders of glycogen metabolism.

Authors:  Elisabetta Gazzerro; Antoni L Andreu; Claudio Bruno
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

8.  Clinical and molecular characterization of McArdle's disease in Brazilian patients.

Authors:  Juliana Gurgel-Giannetti; Gisela Nogales-Gadea; Hélio van der Linden; Túlio Marcus Ribeiro Bellard; Geraldo Brasileiro Filho; Alexandre Varella Giannetti; Eralda Luiza de Castro Concentino; Mariz Vainzof
Journal:  Neuromolecular Med       Date:  2013-05-08       Impact factor: 3.843

Review 9.  Myositis Mimics.

Authors:  E Harlan Michelle; Andrew L Mammen
Journal:  Curr Rheumatol Rep       Date:  2015-10       Impact factor: 4.592

10.  Clinical utility gene card for McArdle disease.

Authors:  Rhonda L Taylor; Mark Davis; Emma Turner; Astrid Brull; Tomás Pinos; Macarena Cabrera; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-01-25       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.